Fig. 2From: CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumorsBoxplots comparing AFP (a) and b-hCG (b) levels before orchiectomy between patients with negative and positive CXCL12 expressionBack to article page